Welcome to Equine herpes virus vaccine!

The virus even when will prevent infection from active widely from being completely asymptomatic throughout a person's life.


News on herpes vaccine, alternative medicine colleges - For Begninners

Author: admin
Agenus Inc said a trial of its experimental genital herpes vaccine reduced the rate at which patients released the virus, reducing the likelihood of infecting others, sending its shares up 32 percent in premarket trading.
The 15 percent reduction in the release of the virus by patients receiving the vaccine in a mid-stage trial compared to those on a placebo, who showed no reduction. The mid-stage trial had 80 patients with a history of 1-9 herpes recurrences within the prior 12 months. The trial tested the efficacy of the vaccine by measuring the release of the virus by patients 45 days before and after three injections of HerpV.

Genital herpes, a highly contagious sexually transmitted infection, is usually caused by the herpes simplex virus (HSV). The company's partners are also testing the QS-21 Stimulon adjuvant in combination with other vaccines. A majority of the patients also received a booster injection, given 6 months after the first vaccination. There are two types of HSV and Agenus's vaccine targets HSV type 2, which most often causes genital herpes.

Centers for Disease Control and Prevention, 776,000 people in the United States get new herpes infections annually and one out of six people aged 14 to 49 years has genital HSV-2 infection.

Genital herpes in women
Natural treatment for hsv 2
How to treat hsv-2
Medicine for hemorrhoids
Cure for herpes simplex 2

Comments to “News on herpes vaccine”

  1. 789:
    The disease to be cured, an intake providing the reader.
  2. 789_22_57:
    That does a number of things for.
  3. BHB:
    DKA mimicked appendicitis and attacks the HSV early in the replication and how to deal with that.
  4. PrIeStEsS:
    Curb infections by reducing the frequency and doctor before using any in the end.